Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Interest in the Development of Advanced Medicines and Vaccines
4.2.2 Increasing Demand for Biologics
4.3 Market Restraints
4.3.1 Complexity of Upstream and Downstream Processing
4.3.2 High Cost of Raw Materials
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.2 Consumables
5.2 By Application
5.2.1 Antibiotics
5.2.2 Recombinant Proteins
5.2.3 Biosimilars
5.2.4 Others
5.3 By Type
5.3.1 Substrate Analysis
5.3.2 Metabolite Analysis
5.3.3 Concentration Detection
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 F. Hoffmann-La Roche AG
6.1.2 Nova Biomedical Corporation
6.1.3 Sartorious AG
6.1.4 YSI, Inc.
6.1.5 Randox Laboratories Ltd
6.1.6 Polestar Technologies
6.1.7 Agilent Technologies
6.1.8 Groton Biosystems
6.1.9 Thermo Fisher Scientific


7 MARKET OPPORTUNITIES AND FUTURE TRENDS